Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Warsaw Genomics provides advanced genetic testing using next generation sequencing for comprehensive identification of gene variants associated with various diseases. The company has performed over 40,000 NGS assays. During the COVID‑19 pandemic, it pivoted to provide high-throughput SARS-CoV‑2 testing while continuing its core focus on genomic medicine for cancer risk assessment and rare disease diagnosis. It operates both as a laboratory and an outpatient clinic offering personalized care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Warsaw Genomics.